-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Clovis Oncology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2010 to 2021.
- Clovis Oncology, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$44.2M, a 23% increase year-over-year.
- Clovis Oncology, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$207M, a 13.2% increase year-over-year.
- Clovis Oncology, Inc. annual Operating Income (Loss) for 2021 was -$226M, a 25.3% increase from 2020.
- Clovis Oncology, Inc. annual Operating Income (Loss) for 2020 was -$302M, a 19.8% increase from 2019.
- Clovis Oncology, Inc. annual Operating Income (Loss) for 2019 was -$377M, a 12.9% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)